Merck Implementing AI –
A New Augmentation Process

German pharmaceuticals firm Merck KGaA’s health-care division is aiming to implement a new AI augmentation process. Merck plans to implement the new process after deciding to switch to an automated supply chain system. The new system will incorporate AI and predictive analytics throughout Merck’s entire supply chain in 2019. Incorporating this type of technology is known to provide a competitive advantage in the industry. Merck already is using forms of AI to show trends, dips, and spikes across 100 products in a pilot program. In 2021, so-called AI augmentation will generate $2.9 trillion in business value and recover 6.2 billion hours of worker productivity, according to forecasts from Gartner Inc. Since the beginning of their implementation, Merck’s CIO, Alessandro de Luca, has seen nothing but positive effects. Their success had led to them to push the pendulum to a fully automated supply chain system across their 5,000 products. Is AI going to be a key element for growth in any industry in the future? Where are there areas where this technology can’t be beneficial to industries of the future?

Want to learn more?

• Read the original Wall Street Journal article here.
• See also our article on advanced technology and how implementing AI and blockchain strategies can radically transform supply chain.
• Sign up for our “North Star” newsletter to get the most important news, insights and profiles on supply chain transformation.